Dan V. Mourich - Search Results

Year	Number of Results
2003	2
2004	1
2005	2
2008	2
2009	3
2010	1
2011	1
2012	2
2013	1
2014	2
2021	1
2022	1
2023	1
2024	0

1

Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology.

Hambly JN, Ruby CE, Mourich DV, Bracha S, Dolan BP. Hambly JN, et al. Among authors: mourich dv. Vet Sci. 2023 May 9;10(5):336. doi: 10.3390/vetsci10050336. Vet Sci. 2023. PMID: 37235419 Free PMC article. Review.

2

Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins.

Van Fossen EM, Grutzius S, Ruby CE, Mourich DV, Cebra C, Bracha S, Karplus PA, Cooley RB, Mehl RA. Van Fossen EM, et al. Among authors: mourich dv. Front Chem. 2022 Feb 21;10:835229. doi: 10.3389/fchem.2022.835229. eCollection 2022. Front Chem. 2022. PMID: 35265586 Free PMC article.

3

A targeted antisense therapeutic approach for Hutchinson-Gilford progeria syndrome.

Erdos MR, Cabral WA, Tavarez UL, Cao K, Gvozdenovic-Jeremic J, Narisu N, Zerfas PM, Crumley S, Boku Y, Hanson G, Mourich DV, Kole R, Eckhaus MA, Gordon LB, Collins FS. Erdos MR, et al. Among authors: mourich dv. Nat Med. 2021 Mar;27(3):536-545. doi: 10.1038/s41591-021-01274-0. Epub 2021 Mar 11. Nat Med. 2021. PMID: 33707773 Free PMC article.

4

Induced IL-10 splice altering approach to antiviral drug discovery.

Panchal RG, Mourich DV, Bradfute S, Hauck LL, Warfield KL, Iversen PL, Bavari S. Panchal RG, et al. Among authors: mourich dv. Nucleic Acid Ther. 2014 Jun;24(3):179-85. doi: 10.1089/nat.2013.0457. Epub 2014 Mar 21. Nucleic Acid Ther. 2014. PMID: 24655055

5

Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing.

Mourich DV, Iversen PL. Mourich DV, et al. Curr Opin Mol Ther. 2009 Apr;11(2):124-32. Curr Opin Mol Ther. 2009. PMID: 19330718 Review.

6

Monoclonal antibodies to two epitopes of beta-human chorionic gonadotropin for the treatment of cancer.

Iversen PL, Mourich DV, Moulton HM. Iversen PL, et al. Among authors: mourich dv. Curr Opin Mol Ther. 2003 Apr;5(2):156-60. Curr Opin Mol Ther. 2003. PMID: 12772505 Review.

7

Antisense approaches to immune modulation for transplant and autoimmune diseases.

Mourich DV, Marshall NB. Mourich DV, et al. Curr Opin Pharmacol. 2005 Oct;5(5):508-12. doi: 10.1016/j.coph.2005.04.018. Curr Opin Pharmacol. 2005. PMID: 16087396 Review.

8

Advanced antisense therapies for postexposure protection against lethal filovirus infections.

Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, Garza NL, Dong L, Mourich DV, Crumley S, Nichols DK, Iversen PL, Bavari S. Warren TK, et al. Among authors: mourich dv. Nat Med. 2010 Sep;16(9):991-4. doi: 10.1038/nm.2202. Epub 2010 Aug 22. Nat Med. 2010. PMID: 20729866

9

Lymphocytic choriomeningitis virus infection in FVB mouse produces hemorrhagic disease.

Schnell FJ, Sundholm S, Crumley S, Iversen PL, Mourich DV. Schnell FJ, et al. Among authors: mourich dv. PLoS Pathog. 2012 Dec;8(12):e1003073. doi: 10.1371/journal.ppat.1003073. Epub 2012 Dec 27. PLoS Pathog. 2012. PMID: 23300439 Free PMC article.

10

Five-step process for screening antisense compounds for efficacy: gene target IL-12Rb2.

Marshall NB, Hauck LL, Mourich DV. Marshall NB, et al. Among authors: mourich dv. Methods Mol Biol. 2011;764:153-68. doi: 10.1007/978-1-61779-188-8_10. Methods Mol Biol. 2011. PMID: 21748639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year